Lumisys to debut low-cost CR reader

Article

X-ray film digitizer firm Lumisys announced that it will begin developing a low-cost computed radiography reader for the medical market. Because a key patent held by CR market leader Fuji expires in 1998, the Sunnyvale, CA-based company believes it can

X-ray film digitizer firm Lumisys announced that it will begin developing a low-cost computed radiography reader for the medical market. Because a key patent held by CR market leader Fuji expires in 1998, the Sunnyvale, CA-based company believes it can enter the CR market without fear of infringing on Fuji's patents.

Although Lumisys would not release many details, project development will begin in the second quarter of 1997 and is expected to take two years. The medical CR reader will employ technology developed for a CR reader that Lumisys has been selling into the nondestructive test market since 1996.

Lumisys revealed the product development plans during a teleconference with industry analysts to discuss its 1997 first-quarter results (end-March). Lumisys posted revenue of $5.8 million, an increase of 14% over the same period in 1996, when Lumisys had sales of $5.1 million.

Now reporting earnings on a fully taxed basis, Lumisys netted normalized income of $788,000 in the first quarter, a 57% gain over normalized earnings from the first quarter of 1996. Earnings per share, however, were slightly below some analysts' expectations, which led to a drop in the company's stock. Lumisys shares closed at $5.88 on April 23, a 52-week low.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.